TY - JOUR
AR - ACR-2020-1-108
TI - Review of Anaesthesia and Analgesia in Patients with COVID-19 in Brazil
AU - Mônica Santos , de Melo
AU - Júlia Ferreira , Nogueira
AU - Lucas Vinicius , Andrade dos Santos
AU - Luis Claudio , Bettamio de Sousa
AU - Raiane , Nascimento Santana
AU - Weslly Jonas , Severo da Silva
AU - Wictor Hugo , de Souza Silva
AU - Makson Gleydson Brito, de Oliveira
JO - Anesthesia and Clinical Research
PY - 2020
DA - Tue 08, Sep 2020
SN - 2733-2500
DO - http://dx.doi.org/10.31487/j.ACR.2020.01.08
UR - https://www.sciencerepository.org/review-of-anaesthesia-and-analgesia-in-patients-with-covid-19_ACR-2020-1-108 
KW - COVID-19, SARS-CoV-2, anaesthetics, analgesics
AB - Severe acute respiratory syndrome (COVID-19), produced by SARS-CoV-2, remains a challenge for
modern medicine and a global health problem. For every 100 patients with COVID-19, about 20 need
hospital care. In addition, some patients will be intubated and others under mechanical ventilation.
Therefore, it is necessary to use drugs as a sedative and analgesic purpose, mainly. Thus, this study brings
a survey on the drugs that can be used for the management of patients with COVID-19 in cases of intubation
and mechanical ventilation in Brazil. In this paper, we will report the classes of anaesthetic and analgesic
drugs. Highlighting the clinical indications for use, pharmacological characteristics of each drug in terms of
doses, pharmacokinetics, pharmacodynamics and possible side effects and, in addition, peculiarities of drugs
related to use in patients with COVID-19, when possible.